Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Aerogen logo — We're devoted to improving the lives of vulnerable patients...

Aerogen

We're devoted to improving the lives of vulnerable patients worldwide through superior aerosol drug delivery.

Founded 1997 Ireland Ireland 551 employees Grant Total: $39.40M Biotechnology, Health Care +1

General Information

Company Name Aerogen
Founded Year 1997
Location Ireland Ireland
Employees 551
Industries Biotechnology, Health Care, Manufacturing
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Aerogen. To contact Aerogen, visit aerogen.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Aerogen compare?

A PDF of Aerogen and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Aerogen soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Aerogen

*Medtech Company of the Year 2020/2021* Aerogen improves the lives of vulnerable patients worldwide through superior aerosol drug delivery – ultimately transforming respiratory care. Dedicated to scientific excellence, Aerogen innovates based on what’s best for the patient and care team and is focused on: - Bringing peace of mind to patients and loved ones by safely and rapidly delivering more medication to the lungs, increasing speed of recovery. - Helping care providers more effectively treat patients, while also empowering them to focus on strategic tasks and reducing their risk of exposure to patient-generated infectious aerosols. - Assisting health systems to improve patient satisfaction and outcomes, reduce admissions, increase hospital discharges and decrease length of stay by more safely and effectively getting medications to patients. - Helping to drive the next generation of effective and safer aerosol medication delivery for the treatment of many of the world’s most difficult health issues, in partnership with pharmaceutical companies.

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant €9.40M 1
Department of Enterprise, Trade and Employment
Department of Enterprise, Trade and Employment
17 Dec 2019
Debt Financing €30.00M 1
European Investment Bank
08 Mar 2019
Private Equity Round Undisclosed 1
Temasek Holdings
Temasek Holdings
05 Nov 2018

FAQ About Aerogen

We're devoted to improving the lives of vulnerable patients worldwide through superior aerosol drug delivery.
Aerogen was founded in 1997.
Aerogen is headquartered in Ireland.
Aerogen operates in Biotechnology, Health Care and Manufacturing.
Aerogen has approximately 551 employees.
Aerogen has completed 3 funding rounds, raising a total of $39.40M. The latest funding stage is Grant.

We're actively collecting intelligence on Aerogen.

Source: BounceWatch company record for Aerogen, https://bouncewatch.com/company/aerogen, updated 5 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes